TEC 22: Central African RepublicGiven the lack of funding support for the Central African Republic trachoma program, TEC recommends to ITI to encourage the national...
TEC 22: TEC Book RecommendationsRecommendation(s): Highlight in country applications areas that are suspected endemic Highlight districts with no partner and no funding...
TEC 22: DFID-ASCEND Lot 1Recommendation: TEC welcomed the participation of colleagues from DFID-ASCEND Lot 1 at TEC 22 and appreciated the information presented....
TEC 22: Compensating for delayed/skipped trachoma treatments (mitigation)Recommendation: Current modelling data predicts that for the majority of trachoma-endemic districts, skipping a round of MDA (i.e., up to...
TEC 22: Zithromax® Supply Chain in the time of COVID-19Recommendation: TEC recommends continued adherence to the “enhanced” greenlight checklist while the pandemic continues. ITI Supply Chain...
TEC 22: Additional fine-tuning needed regarding decision making for treatment of refugee camps/IDPsRecommendation: TEC notes that there is continued difficulty in making evidence-based decisions in the context of refugees and...
TEC 22: Delaying impact surveysRecommendation: ITI supports country programs to make their own determination when they are ready to restart field activities (surveys...
TEC 22: Ensuring access to Zithromax® donation to all at-risk populationsRecommendation: The TEC noted that there are still areas that are unmapped – due in part to insecurity, access issues, and lack of...